Impel Pharmaceuticals to Participate in 2022 Wedbush PacGrow Healthcare Conference
SEATTLE, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus on the central nervous system, today announced that Adrian Adams, Chairman and Chief Executive Officer, and John Leaman, M.D., Chief Financial and Business Officer, will participate in a fireside chat at the 2022 Wedbush PacGrow Healthcare Conference, being held virtually on Tuesday, August 9, 2022, at 12:35 p.m. ET.
A live webcast of the event will be available on the Investors section of the Impel Pharmaceuticals website at https://investors.impelpharma.com/. A replay of the presentation will be availble on the website for 90 days.
About Impel Pharmaceuticals
For additional information about Impel, please visit www.ImpelPharma.com